A commercialization initiative to expand overseas sales of the company’s own pharmaceuticals and broaden its sales markets and revenue opportunities through the supply of active pharmaceutical ingredients (APIs) to other companies and overseas development. This also includes establishing the infrastructure to promote overseas expansion, such as setting up a U.S. subsidiary.